<DOC>
	<DOCNO>NCT00630279</DOCNO>
	<brief_summary>This study estimate efficacy number dose patient pancreatic insufficiency</brief_summary>
	<brief_title>Dose-ranging Study Evaluate Efficacy SLV339 Pancreatic Exocrine Insufficiency Due Chronic Pancreatitis</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<criteria>Subject &gt; 18 year ; Pancreatic exocrine insufficiency confirm documented medical history either pathophysiological direct indirect pancreatic function test clinical symptom steatorrhea stool fat resolve improve substantially upon pancreatic enzyme supplementation ; Patients stable daily dose pancreatic enzyme 3 month ; Subjects CP without partial pancreatectomy due CP , confirm medical history either CT , ERCP , plain film pancreatic calcification , ultrasonography ( calcification , duct dilatation ) , magnetic resonance pancreatography , endoscope ultrasound , radiological diagnosis capture tool Cambridge classification /or histology ; CFA &lt; 80 % time randomization Evidence major surgery ( except gall bladder removal appendectomy ) relevant disease reveal history , physical examination , laboratory assessment may interfere absorption , distribution , metabolism elimination study drug constitute risk factor take study medication ; Investigational drug intake within 90 day prior preassessment visit ; Ileus acute abdomen ; Allergic disease hypersensitivity pneumonitis , aspergillus mediate asthma allergic bronchopulmonary aspergillosis ; Stenosis regurgitation esophagus stomach ; Known HIV infection , acute phase CP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>pancreatic exocrine insufficiency</keyword>
	<keyword>chronic pancreatitis</keyword>
</DOC>